BIO Priorities Include Appropriate Pricing, Chair Mullen Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Biotechnology Industry Organization will also work to strengthen the intellectual property system, the exec tells BIO’s annual meeting.